Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress-Reference-Cited by-同舟云学术

Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress

Published:2022-01 Issue:1 Volume:71 Page:140-143
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Yonekura Syuji,Gotoh Minoru,Okano Mitsuhiro,Kurokawa Tomoya,Maekawa Yuriko,Okubo Kimihiro,Okamoto Yoshitaka

Funder

Torii Pharmaceutical

Publisher

Elsevier BV

Subject

General Medicine,Immunology and Allergy

Reference12 articles.

1. Present state of Japanese cedar pollinosis: the national affliction;Yamada;J Allergy Clin Immunol,2014

2. [Epidemiological survey of allergic rhinitis in Japan 2019];Matsubara;Nippon Jibiinkoka Gakkai Kaiho (Tokyo),2020

3. [Practical Guideline for the Management of Allergic Rhinitis in Japan];Okubo,2020

4. Detection of specific IgE antibodies to Japanese cypress pollen in patients with nasal allergy: a comparative study with Japanese cedar;Ganbo;Auris Nasus Larynx,1995

5. Purification, characterization and molecular cloning of cha o 1, a major allergen of Chamaecyparis obtusa (Japanese cypress) pollen;Suzuki;Mol Immunol,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in immunotherapy approaches for allergic rhinitis;World Journal of Clinical Cases;2024-11-06

2. From the genesis to the present: The evolution of sublingual immunotherapy for cedar pollinosis;Allergology International;2024-07

3. Cha o 3, a cypress pollen allergen, does not activate basophils in Japanese cypress pollinosis;Journal of Allergy and Clinical Immunology: Global;2024-02

4. ヒノキ花粉症に関するClinical Question「ヒノキ花粉抗原を用いた舌下免疫療法の開発は必要か」;Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology);2024

5. Circulating exosomal has-miR-24-3p and has-miR-128-3p reflect early efficacy of sublingual immunotherapy in allergic rhinitis;International Immunopharmacology;2023-11